Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

aTYR PHARMA (ATYR) Return on Capital Employed (2019 - 2025)

aTYR PHARMA (ATYR) has disclosed Return on Capital Employed for 7 consecutive years, with 0.92% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Capital Employed fell 6.0% year-over-year to 0.92%, compared with a TTM value of 0.92% through Dec 2025, down 6.0%, and an annual FY2025 reading of 0.97%, down 25.0% over the prior year.
  • Return on Capital Employed was 0.92% for Q4 2025 at aTYR PHARMA, down from 0.89% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.3% in Q4 2021 and bottomed at 0.92% in Q4 2025.
  • Average Return on Capital Employed over 5 years is 0.6%, with a median of 0.57% recorded in 2022.
  • The sharpest move saw Return on Capital Employed increased 21bps in 2022, then plummeted -40bps in 2024.
  • Year by year, Return on Capital Employed stood at 0.3% in 2021, then crashed by -89bps to 0.57% in 2022, then increased by 9bps to 0.52% in 2023, then tumbled by -66bps to 0.86% in 2024, then fell by -7bps to 0.92% in 2025.
  • Business Quant data shows Return on Capital Employed for ATYR at 0.92% in Q4 2025, 0.89% in Q3 2025, and 0.84% in Q2 2025.